Mesoblast (MESO) R&D In Process: 2020-2024
Historic R&D In Process for Mesoblast (MESO) over the last 3 years, with Dec 2024 value amounting to $574.9 million.
- Mesoblast's R&D In Process fell 0.29% to $574.9 million in Q4 2024 from the same period last year, while for Dec 2024 it was $572.4 million, marking a year-over-year decrease of 0.53%. This contributed to the annual value of $575.7 million for FY2024, which is 0.25% down from last year.
- According to the latest figures from Q4 2024, Mesoblast's R&D In Process is $574.9 million, which was down 0.29% from $576.6 million recorded in Q4 2023.
- In the past 5 years, Mesoblast's R&D In Process registered a high of $581.3 million during Q4 2020, and its lowest value of -$1.2 billion during Q2 2021.
- For the 3-year period, Mesoblast's R&D In Process averaged around $143.4 million, with its median value being $577.0 million (2023).
- Per our database at Business Quant, Mesoblast's R&D In Process fell by 0.34% in 2022 and then rose by 0.33% in 2023.
- Over the past 5 years, Mesoblast's R&D In Process (Quarterly) stood at $581.3 million in 2020, then fell by 0.26% to $579.8 million in 2021, then dropped by 0.33% to $577.9 million in 2022, then dropped by 0.23% to $576.6 million in 2023, then declined by 0.29% to $574.9 million in 2024.
- Its R&D In Process stands at $574.9 million for Q4 2024, versus $576.6 million for Q4 2023 and -$1.2 billion for Q2 2023.